These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 315284)

  • 1. The response to 1,25-dihydroxycholecalciferol and to dihydrotachysterol in adult-onset hypophosphataemic osteomalacia.
    Ahmed KY; Varghese Z; Moorhead JF; Wills MR
    Clin Chim Acta; 1979 Sep; 97(1):33-7. PubMed ID: 315284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1,25-dihydroxycholecalciferol in hypophosphataemic osteomalacia presenting in adults.
    Offermann G; Delling G; Haussler MR
    Acta Endocrinol (Copenh); 1978 Jun; 88(2):408-16. PubMed ID: 580838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D metabolites and bone mineralization in man.
    Bordier P; Rasmussen H; Marie P; Miravet L; Gueris J; Ryckwaert A
    J Clin Endocrinol Metab; 1978 Feb; 46(2):284-94. PubMed ID: 750606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of renal osteodystrophy with calciferol (vitamin D) and related steroids.
    Brickman AS; Norman AW
    Kidney Int; 1973 Aug; 4(2):161-7. PubMed ID: 4364427
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of 6 months therapy with 1,25 (OH)2D3 on bone disease of dialysis patients.
    Malluche HH; Goldstein DA; Massry SG
    Contrib Nephrol; 1980; 18():98-104. PubMed ID: 7353383
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
    Drezner MK; Lyles KW; Haussler MR; Harrelson JM
    J Clin Invest; 1980 Nov; 66(5):1020-32. PubMed ID: 6253520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 1,25-dihydroxycholecalciferol on renal tubular reabsorption of phosphate, intestinal absorption of calcium and bone histology in hypophosphataemic renal tubular rickets.
    Russell RG; Smith R; Preston C; Walton RJ; Woods CG; Henderson RG; Norman AW
    Clin Sci Mol Med; 1975 Mar; 48(3):177-86. PubMed ID: 163719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Experience with 1,25-dihydroxycholecalciferol therapy in undergoing hemodialysis patients with progressive vitamin D2-treated osteodystrophy.
    Prior JC; Cameron EC; Ballon HS; Lirenman DS; Moriarty MV; Price JD
    Am J Med; 1979 Oct; 67(4):583-9. PubMed ID: 386792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoaciduria in chronic renal failure--its relationship to vitamin D and parathyroid status.
    Phillips ME; Havard J; Otterud B
    Am J Clin Nutr; 1980 Jul; 33(7):1541-5. PubMed ID: 6893104
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Idiopathic hypophosphataemic osteomalacia (author's transl)].
    Offermann G; von Herrath D; Delling G
    Dtsch Med Wochenschr; 1976 Nov; 101(46):1684-9. PubMed ID: 186246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistent hypophosphataemia and osteomalacia in dialysis patients not on oral phosphate-binders: Response to dihydrotachysterol therapy.
    Ahmed KY; Varghese Z; Wills MR; Meinhard E; Skinner RK; Baillod RA; Moorhead JF
    Lancet; 1976 Aug; 2(7983):439-42. PubMed ID: 73742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolites of vitamin D in human vitamin-D deficiency: effect of vitamin D3 or 1,25-dihydroxycholecalciferol.
    Papapoulos SE; Clemens TL; Fraher LJ; Gleed J; O'Riordan JL
    Lancet; 1980 Sep; 2(8195 pt 1):612-5. PubMed ID: 6107407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitriol dosage in osteomalacia, hypoparathyroidism and attempted treatment of myositis ossificans progressiva.
    Stamp TC
    Curr Med Res Opin; 1981; 7(5):316-36. PubMed ID: 6894416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemodialysis patients with a unique mineralizing defect unresponsive to 1,25-dihydroxycholecalciferol. Dialysis osteomalacic syndrome.
    Cameron EC; Prior JC; Ballon HS
    Contrib Nephrol; 1980; 18():162-71. PubMed ID: 6986229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Saccharated ferric oxide (SFO)-induced osteomalacia: in vitro inhibition by SFO of bone formation and 1,25-dihydroxy-vitamin D production in renal tubules.
    Sato K; Nohtomi K; Demura H; Takeuchi A; Kobayashi T; Kazama J; Ozawa H
    Bone; 1997 Jul; 21(1):57-64. PubMed ID: 9213008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult-onset vitamin D-resistant osteomalacia with the unresponsiveness to parathyroid hormone.
    Fujita T; Nomura M; Okajima S; Furuya H
    J Clin Endocrinol Metab; 1980 May; 50(5):927-31. PubMed ID: 6246136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical and histological effects of 1,25 dihydroxycholecalciferol (1,25-DHCC) in the osteomalacia of chronic and failure.
    Eastwood JB; Phillips ME; de Wardener HE; Bordier J; Marie P; Arnaud CD; Norman AW
    J Urol Nephrol (Paris); 1974 Dec; 80(12):984-5. PubMed ID: 4617780
    [No Abstract]   [Full Text] [Related]  

  • 18. Autosomal hypophosphataemic bone disease responds to 1,25-(OH)2D3.
    Scriver CR; Reade T; Halal F; Costa T; Cole DE
    Arch Dis Child; 1981 Mar; 56(3):203-7. PubMed ID: 7212758
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of response of 1,25-dihydroxycholecalciferol to exogenous parathyroid hormone in a patient with treated pseudohypoparathyroidism.
    Braun JJ; Birkenhäger JC; Visser TJ; Juttmann JR
    Clin Endocrinol (Oxf); 1981 Apr; 14(4):403-7. PubMed ID: 6266703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25-dihydroxycholecalciferol in renal osteodystrophy. Epiphysiolysis--anticonvulsant therapy.
    Pierides AM; Ellis HA; Dellagrammatikas H; Scott JE; Norman AW
    Arch Dis Child; 1977 Jun; 52(6):464-72. PubMed ID: 879832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.